Showing results (31-40 of 417) with videos related to
Sort By:
Pageof 42
Zeitschrift Fur Rheumatologie|August 30, 2023
[Trabecular bone score in rheumatology : Are there benefits in comparison to bone densitometry alone?]Zhivana Boyadzhieva, Andriko Palmowski, Frank Buttgereit, et al.Arthritis Research & Therapy|July 4, 2012
Energy metabolism and rheumatic diseases: from cell to organismCornelia M Spies, Rainer H Straub, Frank ButtgereitJAMA|June 15, 2016
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic ReviewFrank Buttgereit, Christian Dejaco, Eric L Matteson, et al.Nature Reviews. Rheumatology|September 11, 2020
Author Correction: Monitoring and long-term management of giant cell arteritis and polymyalgia rheumaticaDario Camellino, Eric L Matteson, Frank Buttgereit, et al.Rheumatology (Oxford, England)|July 9, 2018
Prevention of glucocorticoid morbidity in giant cell arteritisFrank Buttgereit, Eric L Matteson, Christian Dejaco, et al.International Review of Cell and Molecular Biology|January 13, 2019
Metabolism of T Lymphocytes in Health and DiseaseTimo Gaber, Yuling Chen, Pierre-Louis Krauß, et al.Clinical and Experimental Rheumatology|October 13, 2015
Novel glucocorticoids: where are we now and where do we want to go?Frank Buttgereit, Cornelia M Spies, J W J BijlsmaRheumatic Diseases Clinics of North America|November 28, 2015
Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell ArteritisEric L Matteson, Frank Buttgereit, Christian Dejaco, et al.Steroids|July 1, 2015
The novel strategy of glucocorticoid drug development via targeting nongenomic mechanismsChun-Lei Jiang, Lei Liu, Zhen Li, et al.Molecular and Cellular Endocrinology|July 17, 2007
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonistsCindy Stahn, Mark Löwenberg, Daniel W Hommes, et al.Pageof 42